No Data
No Data
Alumis And ACELYRIN's Merger Marks A New Era For Late-Stage Biopharma Advancements
Alumis and Acelyrin Sign Merger Agreement
Wells Fargo Maintains Acelyrin(SLRN.US) With Buy Rating
Piper Sandler Sticks to Their Buy Rating for ACELYRIN, INC. (SLRN)
ACELYRIN, INC. (SLRN) Receives a Buy From Wells Fargo
Shareholder Alert: Ademi & Fruchter LLP Investigates Whether ACELYRIN, INC. Is Obtaining a Fair Price for Its Public Shareholders
HannChau : I will not be silent stalker but always will be voice out 'stalker'![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Best Yavo : can I ask what time frames do u look at when trading?
Jaguar8 OP Best Yavo : 1,3,5,15 for active trades
Best Yavo : thank you
MilaDing Best Yavo : When do you usually release Watchlist information?
View more comments...